The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LORIKEET: A phase 2, randomized, open-label study of lorigerlimab plus docetaxel versus docetaxel alone in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Sumit Kumar Subudhi
Stock and Other Ownership Interests - Apricity Health
Consulting or Advisory Role - Amgen; Apricity Health; Arcus Biosciences,; AstraZeneca; Baird; Bayer; Boxer Capital; Breaking Data; Bristol-Myers Squibb; Cancer Expert Now; ChemoCentryx; Clinical Comms Group; Dava Oncology; Dendreon; InProTher Janssen; Janssen; Javelin Oncology; Kahr Medical Ltd; MD Education; Merck; OncLive (owned by Intellisphere, LLC); Pfizer; Polaris; Portage Biotech; Regeneron
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen; Regeneron
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Regeneron
 
Ralph J. Hauke
Stock and Other Ownership Interests - Aethlon
Honoraria - Best Doctors, Inc
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Merck (Inst); Nikang Therapeutics (Inst); Novartis (Inst); Novartis (Inst); US Oncology (Inst)
 
Justin A Call
No Relationships to Disclose
 
Jichao Sun
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
 
Denise Casey
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
 
Xiao X. Wei
Honoraria - OncLive
Consulting or Advisory Role - Novartis; Novartis
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Corvus Pharmaceuticals